CVS Group (LON:CVSG - Get Free Report)'s stock had its "buy" rating reaffirmed by Berenberg Bank in a research report issued on Thursday, Marketbeat.com reports. They presently have a GBX 2,000 ($27.17) price target on the stock. Berenberg Bank's price objective suggests a potential upside of 58.98% from the stock's previous close.
CVS Group Trading Up 5.5%
CVS Group stock traded up GBX 66 ($0.90) during mid-day trading on Thursday, hitting GBX 1,258 ($17.09). The company's stock had a trading volume of 295,601 shares, compared to its average volume of 330,738. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52. The stock's fifty day moving average is GBX 1,244.62 and its two-hundred day moving average is GBX 1,095.68. CVS Group has a 1 year low of GBX 791 ($10.75) and a 1 year high of GBX 1,342 ($18.23). The firm has a market capitalization of £901.65 million, a PE ratio of 43.55, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02.
Insiders Place Their Bets
In related news, insider Richard Fairman acquired 1,644 shares of CVS Group stock in a transaction dated Friday, July 11th. The shares were acquired at an average cost of GBX 1,216 ($16.52) per share, for a total transaction of £19,991.04 ($27,161.74). Also, insider David Wilton purchased 1,000 shares of the business's stock in a transaction on Monday, June 2nd. The stock was acquired at an average price of GBX 1,248 ($16.96) per share, for a total transaction of £12,480 ($16,956.52). 5.83% of the stock is owned by corporate insiders.
CVS Group Company Profile
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
